Drug · DIN 02434962
CANDESARTAN
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 1, 2017.
- Drug Identification Number (DIN)
- 02434962
- Company (DIN owner)
- Actavis Pharma CompanyToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Candesartan C09CA06
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CANDESARTAN CILEXETIL | 32 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 9, 2014: NOC 16423Abbreviated New Drug Submission (ANDS) · Additional product name
Other DINs named CANDESARTAN
- DIN 02377934 · Marketed
- DIN 02377942 · Marketed
- DIN 02388707 · Marketed
- DIN 02388715 · Marketed
- DIN 02422069 · Marketed
- DIN 02528258 · Marketed
- DIN 02528266 · Marketed
- DIN 02388693 · Cancelled Post Market
- DIN 02388901 · Dormant
- DIN 02388928 · Dormant
- DIN 02388936 · Dormant
- DIN 02410478 · Cancelled Pre Market
- DIN 02410486 · Cancelled Pre Market
- DIN 02410494 · Cancelled Pre Market
- DIN 02410508 · Cancelled Pre Market
- DIN 02434377 · Cancelled Pre Market
- DIN 02434520 · Cancelled Pre Market
- DIN 02434954 · Cancelled Pre Market
- DIN 02435845 · Dormant
- DIN 02461609 · Approved